Location History:
- Waukegan, IL (US) (1997 - 2008)
- Antioch, IL (US) (2007 - 2018)
Company Filing History:
21 out of 4,179 
16 out of 822 
2 out of 1,863 
Years Active: 1997-2018
Areas of Expertise:
Title: Bryan K. Sorensen – Innovator in Biochemical Patents
Introduction
Bryan K. Sorensen, based in Antioch, IL, is a notable inventor with an impressive portfolio of 40 patents. His work primarily focuses on pharmaceutical innovations, specifically in the development of compounds that target critical biochemical pathways related to disease treatment.
Latest Patents
Among his most recent contributions to the field are patents related to NAMPT and ROCK inhibitors. These patents disclose innovative isoindoline carboxamide, dihydropyrrolopyridine carboxamide, and dihydropyrrolopyrimidine carboxamide compounds that inhibit the activity of NAMPT. Additionally, he has developed similar compounds aimed at ROCK inhibition. These inventions include compositions that incorporate these compounds and outline methods for treating diseases where NAMPT and ROCK are expressed.
Career Highlights
Bryan's career has been marked by significant contributions while working at prominent companies in the pharmaceutical industry, including Abbott Laboratories Corporation and AbbVie Inc. His expertise has allowed him to make substantial advancements in drug development and biochemistry.
Collaborations
Throughout his career, Bryan has collaborated with notable professionals such as Martin Winn and James T. Link. These partnerships have enhanced the innovation process and contributed to the successful development of his patented technologies.
Conclusion
With a solid foundation in biochemistry and a proven record of patent development, Bryan K. Sorensen continues to be a key player in the field of pharmaceutical innovations. His work, especially in the area of enzyme inhibitors, is paving the way for new therapeutic approaches to treating significant health conditions.